Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0008
+0.0004 (100.00%)
Nov 3, 2025, 4:00 PM EST
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $21.47 thousand as of November 4, 2025. Its market cap has decreased by -99.96% in one year.
Market Cap
21.47K
Enterprise Value
1.97M
Revenue
386.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 21.47K, a decrease of -99.99%. That is a compound annual growth rate of -65.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 10.73K | -99.83% |
| Dec 31, 2024 | 6.17M | -96.96% |
| Dec 29, 2023 | 202.59M | 179.01% |
| Dec 30, 2022 | 72.61M | -64.04% |
| Dec 31, 2021 | 201.95M | -59.37% |
| Dec 31, 2020 | 497.05M | 69.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |